Metraipolis › archive › dc_22c043a8d39b
Prognostic significance of hematological parameters and albumin in BCMA-targeted CAR-T therapy for multiple myeloma — Europe PMC PMID:41479909
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41479909
- DOI
- 10.3389/fimmu.2025.1703394
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T14:16:25.691Z
- SHA-256 of the archived text
f536f281c6f6d3a88e2f776571dbeef19ecd6ffe9596f0ac4b177f268ad26081- Stable URL of this page
https://metraipolis.com/documento/dc_22c043a8d39b
How to cite
Prognostic significance of hematological parameters and albumin in BCMA-targeted CAR-T therapy for multiple myeloma — Europe PMC PMID:41479909 — Europe PMC (en), https://europepmc.org/article/MED/41479909 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_22c043a8d39b (Metraipolis archive dc_22c043a8d39b, sha256 f536f281c6f6d3a88e2f776571dbeef19ecd6ffe9596f0ac4b177f268ad26081)
BibTeX
@misc{dc22c043a8d39b,
title = {Prognostic significance of hematological parameters and albumin in BCMA-targeted CAR-T therapy for multiple myeloma — Europe PMC PMID:41479909},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41479909},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_22c043a8d39b; sha256 f536f281c6f6d3a88e2f776571dbeef19ecd6ffe9596f0ac4b177f268ad26081},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41479909. Agents can read the archived copy with the MCP tool read_document.